| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009802867 |
| P356 | DOI | 10.1007/S00106-008-1762-6 |
| P698 | PubMed publication ID | 18696018 |
| P2093 | author name string | D Jäger | |
| J Krauss | |||
| F Lordick | |||
| P2860 | cites work | KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. | Q27851422 |
| Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer | Q28271324 | ||
| Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck | Q29619277 | ||
| Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancer | Q33635777 | ||
| EGFR and cancer prognosis | Q34399312 | ||
| Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance. | Q34733433 | ||
| Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States | Q34743604 | ||
| Combination of radiotherapy with EGFR antagonists for head and neck carcinoma | Q36795322 | ||
| Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival? | Q37104586 | ||
| The incidence of p53 mutations increases with progression of head and neck cancer | Q38485045 | ||
| Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. | Q40744582 | ||
| Circulating markers in squamous cell carcinoma of the head and neck: a review | Q41458669 | ||
| Mutations of the BRAF gene in squamous cell carcinoma of the head and neck | Q47739089 | ||
| Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. | Q53393724 | ||
| Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction. | Q53454391 | ||
| Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy. | Q53743664 | ||
| [Squamous cell carcinoma-associated antigen (SCC) as a tumor marker in the initial diagnosis of carcinomas of the head and neck region. Results of a prospective study after 24 months] | Q68517627 | ||
| Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer | Q70505754 | ||
| A Reappraisal of the Squamous Cell Carcinoma Antigen as a Tumor Marker in Head and Neck Cancer | Q71783030 | ||
| CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer | Q71783419 | ||
| CYFRA 21-1: A new marker in lung cancer | Q72088051 | ||
| Tumor markers in the diagnosis and follow-up of head and neck cancer: role of CEA, CA 19-9, SCC, TK, and dTTPase | Q72971096 | ||
| Cut-off value determination of CYFRA 21-1 for squamous cell carcinomas of the head and neck (SCCHN) | Q73785656 | ||
| [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen] | Q73852189 | ||
| Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent | Q74380841 | ||
| Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma | Q77603483 | ||
| Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck | Q78378654 | ||
| [Tumour markers] | Q81128508 | ||
| P433 | issue | 9 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 881-885 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | HNO | Q27711112 |
| P1476 | title | [Tumor markers and biomarkers in squamous cell cancer of the head and neck] | |
| P478 | volume | 56 |
Search more.